Epigenetic profiles reveal that ADCYAP1 serves as key molecule in gestational diabetes mellitus (Q2332564)

Summary: Gestational diabetes mellitus (GDM) refers to the condition which shows abnormal glucose metabolism that occurs during pregnancy, while normal glucose metabolism before pregnancy. In the present study, a novel analytical procedure was used to explore the key molecule of gestational diabetes mellitus. First, the weighted pathway model was carried out subsequently to eliminate the gene-overlapping effects among pathways. Second, we assessed the enriched pathways by a combination of Fisher's \(t\)-test and the Mann-Whitney \(U\) test. We carried out the functional principal component analysis by estimating \(F\) values of genes to identify the hub genes in the enriched pathways. Results showed that a total of 4 differential pathways were enriched. The key pathway was considered as the insulin secretion pathway. \(F\) values of each gene in the key pathway were calculated. Three hub molecules were identified as hub differentially methylated genes, namely, \textit{CAMK2B}, \textit{ADCYAP1}, and \textit{KCNN2}. In addition, by further comparing the gene expression data in a validation cohort, one key molecule was obtained, \textit{ADCYAP1}. Therefore, \textit{ADCYAP1} may serve as a potential target for the treatment of GDM.